Compound useful for the treatment of neuropathic pain

Details Compound useful for the treatment of neuropathic pain Compound useful for the treatment of neuropathic pain

2007-05-22

2007-05-22

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

10637299

ABSTRACT:
This invention is directed to pyrimidine and indolone derivatives which are selective antagonists for the GAL3 receptor and are useful for the treatment of neuropathic pain and other abnormalities. This invention also provides a method of treating a subject suffering from an abnormality which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's abnormality. This invention also provides a method of treating an abnormality in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GAL3 receptor antagonist.

REFERENCES:
patent: 5576296 (1996-11-01), Bartfai et al.
patent: 6511827 (2003-01-01), Howard et al.
patent: 7081470 (2006-07-01), Konkel et al.
patent: 514361 (1992-11-01), None
patent: 667340 (1995-08-01), None
patent: WO9212997 (1992-08-01), None
patent: WO9815570 (1998-04-01), None
patent: WO9931130 (1999-06-01), None
patent: WO0002865 (2000-01-01), None
patent: WO0260392 (2002-08-01), None
U.S. Appl. No. 10/638,242, filed May 2004, Konkel et al.
U.S. Appl. No. 10/723,961, filed Jul. 2004, Blackburn et al.
U.S. Appl. No. 11/298,116, filed Dec. 2005, Blackburn et al.
U.S. Appl. No. 11/343,810, filed Jan. 2006, Konkel et al.
U.S. Appl. No. 11/343,989, filed Jan. 2006, Konkel et al.
Swanson, C. J. et al. “Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299” (2005) PNAS vol. 102, No. 48, pp. 17489-17494.
Liu, H. X. et al. “Effect of intrathecal galanin and its putative antagonist M35 on pain begavior in a neuropathic pain model” (2000) Brain Research vol. 886, pp. 67-72.
Silverman, Richard B. The Organic Chemistry of Drug Design and Drug Action, (1992) Published by Academic Press, pp. 65-71.
Ahmad, A., et al., “Identification And Molecular Cloning Of ANovel Galanin Receptor (GALR-2) In Rat Sensory Neurons”,Soc.Neurosci. Abstr. (1996) 22(3): 1682, Abstract No. 661.10 (Exhibit 10).
Ahmad, S., et al., “Molecular Cloning Of A Novel Widely Distributed Galanin Receptor Subtype (GALR2),”International Association for the Study of Pain(IASP Press)(1996) Abstract No. 81: 134 (Exhibit 11).
Ahmad, S. Et al., Astra Pain Control (1996), poster (Exhibit 12).
Bartfai, T., et al, “Galanin Receptor Ligand M40 Peptide Distinguishes Between Putative Galanin- Receptor Subtypes,”PNAS(USA)(1993) 90: 11287-11291 (Exhibit 13).
Branchek, et al., “Galanin Receptor Subtypes,”Trends In Pharmacological Sciences. Elsevier Trends Journal. (Mar. 2000) 21(3): 109-116 (Exhibit 14).
Gustafson, E., et al., “Distribution of a Rat Galanin Receptor mRNA in Rat Brain,”Neuroreport(1996) 7: 953-957 (Exhibit 15).
Kahl, U., et al., “Galanin Receptors,”DN&P(1995) 8(7): 404-410 (Exhibit 16).
O'Donnell, D., et al., “Neuroanatomical Distribution Of A Novel Rat Galanin Receptor Subtype,”Soc. Neurosci. Abstr. (1996) 22(2):1304, Abstract No. 517.9 (Exhibit 17).
Selve et al., “Galanin receptor antagonists attenuate spinal antinociceptive effects of DAMGO, tramadol and non-opioid drugs in rats,”Brain Res. (Oct. 7, 1996) 735(2): 177-187 (Exhibit 18).
Smith, et al., “Cloned Human and Rat Galanin GALR3 Receptors,”The Journal of Biological Chemistry. (Sep. 1998) 273(36): 23321-23326 (Exhibit 19).
Xu, X.J., et al., “New High Affinity Peptide Antagonists to the Spinal Galanin Receptor,”Br. J. Pharmacol. (1995) 116: 2076-2080 (Exhibit 20).
Bionet Research Ltd. Catalog #11L-312S (1-Phenyl-3-{[3-(trifluoromethyl)phenyl]imino}-1,3-dihydro-2H-indol-2-one) (Exhibit 21).
Chemical Abstracts Registry No. 61038-64-0 (Exhibit 22).
Chemical Abstracts Registry No. 41230-77-7 (Exhibit 23).
Chemical Abstracts Registry No. 130186-15-1 (Exhibit 24).
Chemical Abstracts Registry No. 130186-16-2 (Exhibit 25).
Chemical Abstracts Registry No. 130186-17-3 (Exhibit 26).
Chemical Abstracts Registry No. 130186-18-4 (Exhibit 27).
Chemical Abstracts Registry No. 130186-21-9 (Exhibit 28).
Chemical Abstracts Registry No. 130270-13-2 (Exhibit 29).
Chemical Abstracts Registry No. 133939-75-0 (Exhibit 30).
Chemical Abstracts Registry No. 56984-58-8 (Exhibit 31).
Chemical Abstracts Registry No. 77910-42-0 (Exhibit 32).
Chemical Abstracts Registry No. 70010-41-2 (Exhibit 33).
Chemical Abstracts Registry No. 189264-35-5 (Exhibit 34).
Chemical Abstracts Registry No. 88291-04-7 (Exhibit 35).
Chemical Abstracts Registry No. 88291-07-0 (Exhibit 36).
Chemical Abstracts Registry No. 154118-05-5 (Exhibit 37).
Chemical Abstracts Registry No. 155717-81-0 (Exhibit 38).
Chemical Abstracts Registry No. 155717-82-1 (Exhibit 39).
Chemical Abstracts Registry No. 159967-24-5 (Exhibit 40).
Chemical Abstracts Registry No. 138601-94-2 (Exhibit 41).
Chemical Abstracts Registry No. 136647-69-3 (Exhibit 42).
Chemical Abstracts Registry No. 136647-72-8 (Exhibit 43).
Chemical Abstracts Registry No. 77297-28-0 (Exhibit 44).
Chemical Abstracts Registry No. 43002-26-2 (Exhibit 45).
Chemical Abstracts Registry No. 303954-69-2 (Exhibit 46).
Chemical Abstracts Registry No. 122725-53-5 (Exhibit 47).
Chemical Abstracts Registry No. 122803-89-8 (Exhibit 48).
Chemical Abstracts Registry No. 303149-10-2 (Exhibit 49).
Chemical Abstracts Registry No. 303149-08-8 (Exhibit 50).
Chemical Abstracts Registry No. 303149-06-6 (Exhibit 51).
Chemical Abstracts Registry No. 303984-47-6 (Exhibit 52).
Chemical Abstracts Registry No. 303149-14-6 (Exhibit 53).
Chemical Abstracts Registry No. 303149-12-4 (Exhibit 54).
Chemical Abstracts Registry No. 303984-51-2 (Exhibit 55).
Chemical Abstracts Registry No. 303984-49-8 (Exhibit 56).
Chemical Abstracts Registry No. 303954-48-7 (Exhibit 57).
Chemical Abstracts Registry No. 303984-52-3 (Exhibit 58).
Chemical Abstracts Registry No. 303984-60-3 (Exhibit 59).
Chemical Abstracts Registry No. 303984-61-4 (Exhibit 60).
Chemical Abstracts Registry No. 303984-62-5 (Exhibit 61); and.
Chemical Abstracts Registry No. 303984-68-1 (Exhibit 62).

Affiliated with

Also associated with

Rating

Compound useful for the treatment of neuropathic pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compound useful for the treatment of neuropathic pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound useful for the treatment of neuropathic pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3792384